Study of antibiotic resistance pattern in methicillin resistant staphylococcus aureus with special reference to newer antibiotic

Journal of Global Infectious Diseases

Volumn 7, Issue 2, 2015, Pages 78-84

  Kaur, Dardi Charan ^a   Chate, Sadhana Sanjay ^a  

^a Maharashtra Institute of Medical Education and Research (MIMER Medical College)   (India)

Author keywords

Ceftaroline; Daptomycin; inducible clindamycin resistance; Linezolid; Mupirocin resistance; Newer antibiotic; PDR; Telavancin; XDR

Indexed keywords

CEFOXITIN; CEFTAROLINE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; LINEZOLID; MIKAMYCIN B; MINOCYCLINE; MOXIFLOXACIN; OXACILLIN; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; TELAVANCIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

EID: 84930467145     PISSN: 0974777X     EISSN: 09748245     Source Type: Journal    
DOI: 10.4103/0974-777X.157245     Document Type: Article

References (30)

1. Patel H, Shah A, Mistry M, Chanda S. In vitro antimicrobial susceptibility study in clinical isolates of Streptococci and Enterococci. Afr J Micro Res 2011;5:1374-8.
2. Livermore DM. Antibiotic resistance in Staphylococci. Int J Antimicrob Agents 2000;16:S3-10.
3. Zapun A, Contreras-Martel C, Vernet T. Penicillin-binding 2. Proteins and beta-lactam resistance. FEMS Microbiol Rev 2008;32:361-85.
4. Clinical and Laboratory Standards Institute (CLSI). M100-S21: Performance standards for antimicrobial susceptibility testing. 2012; 32. 21 st Informational Supplement. Wayne, PA, USA.
5. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-81.
6. Debasmita D, Shakti R, Mahesh CS, Lolly P, Debata NK, Rabindra NP. Surveillance of infection status of drug resistant Staphylococcus aureus in an Indian teaching hospital. Asian Pac J Trop Dis 2013;3:133-42.
7. Verma S, Joshi S, Chitnis V, Hemwani N, Chitnis D. Growing problem of methicillin resistant Staphylococci: Indian Scenario. Indian J Med Sci 2000;54:535-40.
8. Elixhauser A, Steiner C. Infections with Methicillin-resistant Staphylococcus Aureus (MRSA) in U.S. Hospitals, 1993-2005. HCUP Statistical Brief #35. July 2007. Agency for Health care Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb35.pdf
9. David MZ, Daum RS. Community-associated methicillin resistant Staphylococcus aureus: Epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010;23:616-87.
10. Maria MT, Bradley DK, Judith NS, Steven DB. Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007. Antimicrob Agents Chemother 2009;53:1735-8.
11. Krause KM, Renelli M, Difuntorum S, Wu TX, Debabov DV, Benton BM. In Vitro activity of telavancin against resistant gram-positive bacteria. Antimicrob Agents Chemother 2008;52:2647-52.
12. Diederen BM, Duijn IV, Willemse P, Klutymans JW. In vitro activity of daptomycin against methicillin resistant Staphylococcus aureus including heterogeneously glycopeptide resistant strains. Antimicrob Agents Chemother 2006;50:3189-91.
13. Falagas ME, Bliziotis IA. Pandrug-resistant Gram-negative bacteria: The dawn of the post antibiotic era? Int J Antimicrob Agent 2007;29:630-6.
14. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs: No drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1-12.
15. Pantosti A, Sanchini A, Monaco M. Mechanisms of antibiotic resistance in Staphylococcus aureus. Future Microbiol 2007;2:323-34.
16. Garrison MW, Nuemiller JJ. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin resistant Staphylococcus aureus and vancomycin-resistant Enterococci. Int J Antimicrob Agent 2007;29:191-6.
17. Deurenberg RH, Vink C, Kalenic S, Friedrich AW, Bruggeman CA, Stobberingh EE. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2007;13:222-35.
18. Slonczewski JL, Foster JW. Microbiology, an evolving science. 1 st Edition; New York: WW Norton; 2009. p. 1-1039.
19. Laudano JB. Ceftaroline fosamil: A new broad-spectrum cephalosporin. J Antimicrob Chemother 2011;66 Suppl 3: iii11-8.
20. Clark C, McGhee P, Appelbaum PC, Kosowska-Shick K. Multistep resistance development studies of ceftaroline in gram-positive and-negative bacteria. Antimicrob Agents Chemother 2011;55:2344-51.
21. Clark C, McGhee P, Appelbaum PC, Kosowska-Shick K. Multistep resistance development studies of ceftaroline (CPT) with Streptococcus pneumoniae, Streptococcus pyogenes, staphylococci, and enterococci. In: Abstracts of the Fiftieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, MA, 2010. Poster #E-813. American Society for Microbiology, Washington, DC, USA.
22. Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones NR, Turnidge JD. Antimicrobial susceptibility of gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin and teicoplanin: A SENTRY program report (2003-2004). Int J Antimicrob Agents 2007;30:143-9.
23. Celikbilek N, Ozdem B, Gurelik FC, Guvenman S, Guner HR, Acikgoz ZC. Invitro susceptibility pattern of methicillin-resistant Staphylococcus aureus to Vancomycin, teicoplanin, linezolide and daptomycin. Mikrobiyol Bul 2011;45:512-8.
24. Gu B, Kelesidis T, Tsiodras S, Hindler J, Humphries RM. The emerging problem of linezolid-resistant Staphylococcus. J Antimicrob Chemother 2012;68:4-11.
25. Nagarajan A, Saravanan M, Padma K. Emergence of Methicillin-Resistant Staphylococcus aureus ST239 with High Level Mupirocn and Inducible Clindamycin resistance in a Tertiary care centre in Chennai, South India. J Clin Microbiol 2012;50:3412-3.
26. Fokas S, Fokas S, Tsironi M, Kalkani M, Dionysopouloy M. Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp. Clin Microbiol Infect 2005;11:337-40.
27. Angel MR, Balaji V, Prakash J, Brahmandathan KN, Mathews MS. Prevalence of inducible clindamycin resistance in gram positive organisms in a tertiary care centre. Indian J Med Microbiol 2008;26:262-4.
28. Nicholson AM, Thoms C, Wint H, Didier M, Willis R, McMorris N, et al. The detection of mupirocin resistance and the distribution of methicillin resistant Staphylococcus aureus at the University Hospital of the West Indies, Jamaica. West Indian Med J 2010;59:509-13.
29. McDougal LK, Fosheim G, Patel JB. Team ABCs. Emergence of resistance among USA 300 MRSA isolates causing invasive disease in the US [abstract C1-166]. In: Program and abstracts of the 48th Annual ICAAC/IDSA 46th Annual Meeting (Washington, DC); 2008. p. 103.
30. Perron GG, Lee AE, Wang Y, Huang WE, Barraclough TG. Bacterial recombination promotes the evolution of multi-drug-resistance in functionally diverse populations. Proc Biol Sci 2012;279:1477-84.